Drug intelligence / Profile preview

harmala

Development stage
Unknown
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Oral
01

Overview

Harmala refers to *Peganum harmala* (commonly known as Syrian rue or harmal), a perennial herb native to the Mediterranean and East Asia, as well as the beta-carboline alkaloids (such as harmine, harmaline, and harmalol) derived from its seeds. Historically utilized in traditional medicine across the Middle East and Central Asia, harmala is well-characterized for its psychoactive, anti-inflammatory, and antimicrobial properties. Mechanistically, its primary active constituents act as potent, reversible inhibitors of monoamine oxidase A (MAO-A), which prevents the breakdown of monoamine neurotransmitters like serotonin and norepinephrine. Additionally, harmala alkaloids inhibit acetylcholinesterase (AChE) and dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), contributing to their neuroprotective, cognitive-enhancing, and potential antidiabetic effects. Due to its MAO-inhibiting properties, harmala is also used entheogenically to render other psychoactive substances, such as dimethyltryptamine (DMT), orally active.

Other names
African rueesfandespandharmalharmala alkaloidsPeganum harmalaSyrian ruewild rue
02

Targets

AcetylcholinesteraseButyrylcholinesteraseDYRK1A (Dual-specificity tyrosine-phosphorylation-regulated kinase 1A)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on harmala.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on harmala.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call